Envisagenics
Business Services · New York, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
Suites Long Island City 140 and 150 30-0...Phone Number
(516) 847-5485Website
www.envisagenics.comRevenue
$10.1 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
2
2
1
2
1
1
About Envisagenics
Envisagenics is a biotechnology company that is focused on the development of RNA splicing therapeutics utilizing artificial intelligence.Explore more
Envisagenics Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Envisagenics your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Congratulate Masked Content for being promoted to Masked Content at Envisagenics
Funding: Get notified immidiatlly once Envisagenics has new funding data
Click to see if Envisagenics had a recent Job posting/layoffs
Check out if Envisagenics is spiking on competitors!
Earning: See what the market has to say on Envisagenics recently announced quarterly report
Check if Envisagenics has recently received funding, and reach out quickly before it becomes old news!
Product Launch: Get notified when Envisagenics launches new products
Website visits: Recent activity has been detected on your website
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Envisagenics, which may be a good buyer, showed buying intent in Masked Content Topic
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find 2 more new buyers
Compare Similar Companies to Envisagenics
Compare insights from companies similar to Envisagenics, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Envisagenics is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
Envisagenics is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about Envisagenics.
Envisagenics financials insights
Gather financial insights about Envisagenics, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2015
Angel/Seed
$100K
2017
Angel/Seed
$2.5M
Angel/Seed
$2.4M
2020
Debt
$150K
2021
Debt
$284K
Envisagenics Tech Stack
A closer look at the technologies used by Envisagenics
Most Recent Scoops
Project
, according to a mid-level source in Operations Management, is in the midst of initiatives related to artificial intelligence and machine learning. Envisagenics is currently evaluating vendors to support these efforts.
Machine Learning, Artificial Intelligence, Operations
Project
, according to a mid-level source in Operations Management, has completed initiatives related to approval management within the last nine months.
Records Management, Workforce Management, Operations
Project
, according to a mid-level source in Operations Management, is planning to begin initiatives related to strategy and innovation roadmapping tools software within six to nine months. Envisagenics is currently evaluating vendors to support these efforts.
Enterprise Software, Software, Corporate Strategy, Operations
Pain Point
Project
, according to a mid-level source in Operations Management, is planning to remediate challenges related to professional services automation software.
Pain Point, Automation, Enterprise Software, Software, Workforce Management, Operations
Project
Document Management, Software, Operations
Envisagenics News & Media
Former Departmental CSO of Eli Lilly Joins Envisagenics Board of Directors
NEW YORK, July 16, 2024 /PRNewswire/ -- Envisagenics, an AI-driven RNA splicing therapeutics company, today announced the appointment of Kalpana Merchant, Ph.D. to its Board of Directors. Dr. Merchant's appointment comes on the heels of Envisagenics' recent Series B financing announcement....Envisagenics Raises Series B to Fuel AI-Enabled Novel Therapeutic Pipeline and Expand Depth and Breadth of Commercial Offerings
NEW YORK, June 5, 2024 /PRNewswire/ -- Envisagenics, an AI-driven revenue generating biotechnology company focused on discovery and development of novel RNA splicing therapeutics, today announced a Series B fundraising round with participation from existing investors Third Kind Venture...Envisagenics Validates AI/ML Approach for RNA Target Identification and SSO Therapeutic Development
Results from evaluation of the company's SpliceCore® AI/ML platform in Triple Negative Breast Cancer published in Molecular Systems Biology NEW YORK, April 25, 2024 /PRNewswire/ -- Envisagenics, an AI-driven biotechnology company, today announced the publication in the journal Molecular...Envisagenics is Awarded Another SBIR Grant From the National Cancer Institute to Commercialize its AI/ML Platform for Immunotherapy Development
NEW YORK, Aug. 2, 2022 /PRNewswire/ -- Envisagenics, Inc., a New York-based biotechnology company leveraging artificial intelligence (AI) and RNA-splicing analytics for discovery and development of disease specific therapeutics, announced today that it was awarded a Small Business...
Read more news
Top Business Services Companies
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Envisagenics
Sign Up For FreeTo access detailed company insights
Envisagenics is a biotechnology company that is focused on the development of RNA splicing therapeutics utilizing artificial intelligence.... Read More
